Dergiler / Hand and Microsurgery / 2020 / Cilt: 9 - Sayı: 3

Trigger finger and amyloid cardiomyopathy, usual suspect; Amyloid deposition

Sayfa
120–127
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Tenosynovial biopsy is a low-risk procedure that may guide to cardiologic examination of patients with positive biopsy and it will contribute to early diagnosis of cardiac amyloidosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to investigate the amyloid deposition in patients with trigger finger disease, to analyze the factors affecting amyloid deposition.
📊
Temel Bulgular & Veri:Methods: Consecutive 68 patients with trigger finger treated by open release between September 2018 and November 2019 in two different hospitals were included in this study.
💡
Sonuç & Katkı:Tenosynovial biopsy is a low-risk procedure that may guide to cardiologic examination of patients with positive biopsy and it will contribute to early diagnosis of cardiac amyloidosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: The aim of this study was to investigate the amyloid deposition in patients with trigger finger disease, to analyze the factors affecting amyloid deposition. In addition, we aimed to research the presence of cardiac amyloidosis in patients with amyloid deposition in flexor pulleys. Methods: Consecutive 68 patients with trigger finger treated by open release between September 2018 and November 2019 in two different hospitals were included in this study. Idiopathic trigger fingers were solely included. Patients with systemic rheumatoid diseases, chronic renal failure under hemodialysis, gout, tuberculous synovitis and previously diagnosed systemic amyloidosis including familial amyloid poly- neuropathy or multiple myeloma, pregnant patients, patients who were previously had steroid injected injections were excluded. Demographic data, other concomitant diseases and previous carpal tunnel surgeries were recorded. Immunoperoxidase and immunofluorescence methods were used to determine the amyloid presence and subtype in pathological A1 pulley specimens. Patients with amyloid deposition in biopsy specimen were further evaluated for cardiac involvement of amyloidosis. Results: The study population consisted of 18 men and 50 women with a mean age of 57,6 ± 12,2 years. Of 68 patients with trigger finger, 6 (8,8%) showed amyloid deposition in the tenosynovial tissue; and all amyloid deposits were specifically immunolabeled only with the anti-TTR antibody. No evidence of cardiac amyloidosis is found in patients with localized amyloid deposition. Conclusion: Hand surgeons should be aware of the association trigger finger and amyloidosis and consider biopsy of tenosynovial tissue particularly in patients with older age, DM, prior carpal tunnel release surgery and multi-finger involvement. Tenosynovial biopsy is a low-risk procedure that may guide to cardiologic examination of patients with positive biopsy and it will contribute to early diagnosis of cardiac amyloidosis.

🔖

Bu Makaleye Atıf Yap

Akgun, U., Catal, B., Cimen, O., Turkmen, I., Azboy, I. (2022). Trigger finger and amyloid cardiomyopathy, usual suspect; Amyloid deposition. Hand and Microsurgery, Cilt: 9 - Sayı: 3, 120–127. https://ajindex.com/articles/531796

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (19)

  1. Fahey JJ, Bollinger JA. Trigger-finger in adults and children. J Bone Joint Surg Am 1954;36:1200-18
  2. Strom L. Trigger finger in diabetes. J Med Soc N J 1977;74:951-4
  3. Akhtar S, Bradley MJ, Quinton DN, Burke FD. Management and referral for trigger finger/thumb. BMJ 2005;331:30-3
  4. Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allieu Y. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am 1995;20:109-14
  5. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-96
  6. Siddiqi OK, Ruberg FL. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med 2018;28:10-21
  7. Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. Blood Cancer J 2018;8:44
  8. Papa R, Lachmann HJ. Secondary, AA, Amyloidosis. Rheum Dis Clin North Am 2018;44:585-603
  9. Finsterer J, Iglseder S, Wanschitz J, Topakian R, Loscher WN, Grisold W. Hereditary transthyretin- related amyloidosis. Acta Neurol Scand 2019;139:92-105
  10. Brunjes DL, Castano A, Clemons A, Rubin J, Maurer MS. Transthyretin Cardiac Amyloidosis in Older Americans. J Card Fail 2016;22:996-1003
  11. Corlin DB, Heegaard NH. β(2)-microglobulin amyloidosis. Subcell Biochem 2012;65:517-40
  12. Vergaro G, Aimo A, Barison A, Genovesi D, Buda G, Passino C, et al. Keys to early diagnosis of carwww diac amyloidosis: red flags from clinical, laboratory and imaging findings. Eur J Prev Cardiol 2019:2047487319877708
  13. Villiaumey J, Larget-Piet B, Pointud P. Articular complications of Kahler's disease. Results of a survey of 1953 cases of plasmocytic myelomas. Rev Rhum Mal Osteoartic 1975;42:25-34
  14. Gertz MA, Kyle RA. Primary systemic amyloidosis-- a diagnostic primer. Mayo Clin Proc 1989;64:1505-19
  15. Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Dryll A. Destructive Spondylarthropathy in Hemodialyzed Patients. Arthritis Rheum 1984;27:369-75
  16. Resnick D, Niwayama G. Amyloidosis. In: Resnick DN (ed.) Diagnosis of Bone and Joint Disorders 2nd edition. WB Saunde rs Co, United States, 1988:2387-95
  17. Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, et al. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol 2018;72:2040-50
  18. Cordiner-Lawrie S, Diaz J, Burge P, Athanasou NA. Localized amyloid deposition in trigger finger. J Hand Surg Br 2001;26:380-3
  19. Wright JR, Calkins E, Humphrey RL. P